Global Genetic Engineering Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Devices;
PCR, Gene Gun, and Gel Assemblies.By Techniques;
Artificial Selection, Cloning, Gene Splicing, and Others.By End User;
Research Institutes, Academic Institutes, Pharmaceutical Industries, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Genetic Engineering Market (USD Million), 2021 - 2031
In the year 2024, the Global Genetic Engineering Market was valued at USD 4,912.49 million. The size of this market is expected to increase to USD 10,361.01 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.3%.
The global genetic engineering market represents a dynamic and rapidly evolving sector at the forefront of biotechnology innovation. Genetic engineering, also known as genetic modification or genetic manipulation, involves the manipulation of an organism's genetic material using biotechnological tools and techniques to achieve specific outcomes. These outcomes may include the creation of genetically modified organisms (GMOs), development of novel gene therapies, production of recombinant proteins, and engineering of agricultural crops with desired traits. The global genetic engineering market encompasses a wide range of applications across diverse sectors, including healthcare, agriculture, industrial biotechnology, and environmental remediation, driving innovation and addressing pressing challenges in human health, food security, and sustainability.
In the healthcare sector, genetic engineering plays a pivotal role in advancing precision medicine, personalized therapeutics, and gene-based therapies for the treatment of genetic disorders, cancer, infectious diseases, and chronic conditions. The advent of genome editing technologies such as CRISPR-Cas9 has revolutionized the field of molecular biology, enabling precise modification of DNA sequences in living organisms and offering unprecedented opportunities for therapeutic intervention and disease prevention. Gene editing tools are being used to develop innovative gene therapies, gene editing-based drugs, and cell-based therapies, providing new avenues for treating previously incurable diseases and improving patient outcomes. Moreover, genetic engineering is driving advancements in diagnostic testing, pharmacogenomics, and biomarker discovery, facilitating early disease detection, targeted drug development, and personalized treatment strategies tailored to individual patient characteristics and genetic makeup.
In the agriculture sector, genetic engineering plays a crucial role in enhancing crop productivity, nutritional quality, and resilience to biotic and abiotic stresses, thereby contributing to global food security and sustainable agriculture. Genetically modified (GM) crops engineered with traits such as herbicide tolerance, insect resistance, and drought tolerance offer farmers cost-effective solutions for pest management, weed control, and resource conservation, reducing reliance on chemical inputs and promoting environmentally sustainable farming practices. Moreover, genetic engineering is enabling the development of biofortified crops with enhanced nutritional profiles, such as vitamin-enriched rice and iron-fortified beans, addressing malnutrition and micronutrient deficiencies in vulnerable populations worldwide. Additionally, genetic engineering techniques are being used to develop disease-resistant livestock, enhance livestock productivity, and improve animal welfare, supporting the livestock industry and ensuring a safe and sustainable food supply.
Global Genetic Engineering Market Recent Developments
-
In April 2023, Ginkgo Bioworks announced its acquisition of StrideBio's adeno-associated virus (AAV) capsid discovery and engineering platform assets. This strategic move aims to enhance Ginkgo's end-to-end AAV gene therapy development platform. The acquisition will allow Ginkgo to integrate StrideBio's capabilities and intellectual property, providing customers with new tools to effectively target a wide range of tissue types.
-
In October 2021, Merck Life Science licensed its proprietary CRISPR-Cas9 technology to Cellecta for the development of next-generation medicines. This licensing agreement empowers researchers and scientists to create treatments for hereditary blood disorders, cancers, and ophthalmological diseases. The collaboration aims to leverage the advanced capabilities of CRISPR-Cas9 to drive innovations in therapeutic solutions across these critical areas of healthcare.
Segment Analysis
The Global Genetic Engineering Market has been segmented by Devices, Techniques, End User, and Geography, devices into CRISPR-based devices, gene synthesis devices, sequencing devices, and others. CRISPR-based devices are among the most revolutionary tools in genetic engineering, allowing precise modification of genes with high accuracy and efficiency. This technology has seen widespread adoption in research, agricultural biotechnology, and medical applications. Gene synthesis devices are used to create synthetic genes by chemically assembling nucleotides, enabling advancements in gene therapy and biotechnology. Sequencing devices play a crucial role in genetic engineering by allowing for the decoding of genetic material, which is essential for studying genetic variations and understanding gene functions. The "others" category includes additional tools like electrophoresis devices and gene expression analysis equipment, which are essential for various genetic studies and applications.
The market is segmented by techniques into gene cloning, gene editing, gene expression analysis, and others. Gene cloning involves creating identical copies of a particular gene, which is vital for studying gene functions, producing proteins, or creating genetically modified organisms (GMOs). Gene editing, particularly using technologies like CRISPR-Cas9, is a technique that allows precise alterations to the DNA of organisms and has applications in gene therapy, agriculture, and disease modeling. Gene expression analysis helps researchers understand how genes are turned on or off, providing insights into cellular processes and disease mechanisms. The "others" category includes techniques like RNA interference and synthetic biology, which are also important for advancing genetic engineering technologies and applications.
The end-user segment includes academic and research institutions, pharmaceutical and biotechnology companies, and hospitals. Academic and research institutions are major players in the genetic engineering market, conducting basic and applied research in genomics, molecular biology, and genetic modification technologies. Pharmaceutical and biotechnology companies utilize genetic engineering for drug development, gene therapies, and the creation of genetically modified organisms for research and production. Hospitals are increasingly adopting genetic engineering techniques, particularly in gene therapy and precision medicine, where tailored treatments based on genetic modifications are used to treat diseases such as cancer, genetic disorders, and chronic illnesses. Geographically, North America and Europe dominate the market, driven by advanced research facilities, substantial investments in biotechnology, and strong regulatory frameworks. However, the Asia-Pacific region is experiencing rapid growth in the genetic engineering market, fueled by increased investments in biotech research, improved healthcare infrastructure, and rising interest in genetic engineering technologies for agricultural and medical applications.
Global Genetic Engineering Segment Analysis
In this report, the Global Genetic Engineering Market has been segmented by Devices, Techniques, End User, and Geography.
Global Genetic Engineering Market, Segmentation by Devices
The Global Genetic Engineering Market has been segmented by Devices into PCR, Gene Gun and Gel Assemblies.
The Global Genetic Engineering Market is segmented by devices into PCR (Polymerase Chain Reaction), gene gun, and gel assemblies, each playing a pivotal role in genetic modification and research. PCR is one of the most widely used techniques in genetic engineering, enabling the amplification of DNA segments for analysis and manipulation. It is crucial in gene cloning, sequencing, diagnostics, and gene expression studies. PCR devices, with advancements such as real-time PCR, are essential for precision and efficiency in genetic research, particularly in fields like diagnostics, forensic science, and molecular biology. The ability to rapidly amplify DNA makes PCR an indispensable tool in both academic and clinical laboratories.
Gene guns are another important device in genetic engineering, particularly for applications involving the direct delivery of genetic material into cells or tissues. This device is used for gene transfer in plants, animals, and microorganisms, especially in the development of genetically modified organisms (GMOs) and in gene therapy research. Gene guns work by using high-pressure gas to shoot DNA-coated particles into cells, making them an efficient tool for creating transgenic organisms and conducting plant genetic engineering. Their application is particularly important in agriculture and biotechnology, where precise genetic modifications are necessary for improving crop traits and for research into disease-resistant plants.
Gel assemblies, such as electrophoresis systems, are essential devices for analyzing genetic material. Gel electrophoresis allows researchers to separate DNA, RNA, and proteins based on their size and charge, making it a vital tool in genetic analysis and cloning. These devices are widely used in conjunction with PCR to verify the presence of target genes, assess gene expression, and purify genetic materials for further experimentation. The growing demand for precise and reliable genetic engineering methods is driving the market for these devices, particularly in research, diagnostics, and biotechnology sectors. Geographically, North America and Europe dominate the market due to their strong biotechnology sectors and advanced research infrastructure, while the Asia-Pacific region is expected to experience rapid growth as genetic engineering technologies become more widely adopted in emerging markets.
Global Genetic Engineering Market, Segmentation by Techniques
The Global Genetic Engineering Market has been segmented by Techniques into Artificial Selection, Cloning, Gene Splicing, and Others.
Artificial selection, also known as selective breeding, represents a foundational technique within the field of genetic engineering, dating back thousands of years to the domestication of plants and animals by early human societies. This technique involves the deliberate selection and breeding of organisms with desired traits, such as higher crop yields, improved disease resistance, or superior livestock characteristics, to propagate desirable genetic variations within populations over successive generations. Artificial selection has played a crucial role in shaping agricultural crops, livestock breeds, and ornamental plants, enabling humans to enhance desired traits and adapt organisms to specific environmental conditions or human needs. Today, modern breeding techniques such as marker-assisted selection and genomic selection leverage advances in genomics and bioinformatics to accelerate the breeding process, identify genetic markers associated with target traits, and facilitate the development of improved crop varieties and animal breeds with enhanced productivity, nutritional quality, and resilience to biotic and abiotic stresses.
Cloning represents another important technique in genetic engineering, enabling the replication of identical copies of an organism or genetic material. Cloning techniques such as somatic cell nuclear transfer (SCNT) allow scientists to produce genetically identical copies of animals, plants, or cells for various research, agricultural, and biomedical applications. In animal cloning, the nucleus of a somatic cell is transferred into an enucleated egg cell, resulting in the creation of a genetically identical clone with the same nuclear DNA as the donor cell. Animal cloning has been used to produce livestock clones for agricultural purposes, model organisms for scientific research, and cloned pets for commercial and personal reasons. In plant cloning, techniques such as tissue culture and vegetative propagation enable the clonal propagation of plants from somatic cells or specialized tissues, allowing for the rapid multiplication of elite plant varieties, conservation of endangered species, and production of disease-free planting materials for agriculture and horticulture.
Gene splicing, also known as recombinant DNA technology, represents a cornerstone technique in genetic engineering, enabling the precise manipulation and recombination of DNA sequences from different sources to create novel genetic constructs with desired properties. Gene splicing techniques such as restriction enzyme digestion, DNA ligation, polymerase chain reaction (PCR), and gene cloning allow scientists to isolate, modify, and insert specific genes or gene fragments into host organisms, resulting in the production of recombinant proteins, genetically modified organisms (GMOs), and gene-edited organisms with altered traits or functionalities. Recombinant DNA technology has revolutionized fields such as biopharmaceuticals, agriculture, and industrial biotechnology, enabling the production of therapeutic proteins, transgenic crops, and microbial strains with valuable industrial applications. Recent advancements in genome editing technologies, such as CRISPR-Cas9, have further expanded the capabilities of gene splicing, enabling precise and efficient genome editing in a wide range of organisms for therapeutic, agricultural, and research purposes.
Global Genetic Engineering Market, Segmentation by End User
The Global Genetic Engineering Market has been segmented by End User into Research Institutes, Academic Institutes, Pharmaceutical Industries, and Others.
Research institutes represent a significant end-user segment within the global genetic engineering market, comprising organizations dedicated to scientific research, discovery, and innovation across diverse fields of study. These research institutes play a crucial role in advancing fundamental knowledge in genetics, molecular biology, and biotechnology, as well as developing novel methodologies, tools, and technologies for genetic engineering. Research institutes conduct basic and applied research in areas such as genome editing, gene therapy, synthetic biology, and genetic modification of organisms, contributing to advancements in human health, agriculture, industry, and environmental science. Moreover, research institutes serve as hubs for interdisciplinary collaboration, training the next generation of scientists, and disseminating research findings through publications, conferences, and scientific networks, driving innovation and knowledge exchange within the global scientific community.
Academic institutes represent another key end-user segment in the global genetic engineering market, encompassing universities, colleges, and educational institutions engaged in teaching, training, and research in genetics, biotechnology, and related disciplines. These academic institutes play a vital role in educating students, training future scientists, and conducting cutting-edge research in genetic engineering. Academic institutes offer undergraduate and graduate programs in genetics, molecular biology, and biotechnology, providing students with theoretical knowledge and practical skills in genetic engineering techniques and applications. Moreover, academic researchers contribute to the advancement of genetic engineering through basic and translational research, collaborating with industry partners, government agencies, and other stakeholders to address pressing challenges in healthcare, agriculture, and environmental sustainability. Additionally, academic institutes serve as catalysts for innovation, entrepreneurship, and technology transfer, fostering collaborations between academia and industry to translate research discoveries into real-world applications and commercial products.
Pharmaceutical industries represent a major end-user segment in the global genetic engineering market, encompassing biopharmaceutical companies, pharmaceutical manufacturers, and contract research organizations (CROs) involved in drug discovery, development, and production. These pharmaceutical industries utilize genetic engineering technologies to develop novel therapeutics, biologics, and vaccines for the treatment and prevention of human diseases. Genetic engineering enables the production of recombinant proteins, monoclonal antibodies, gene therapies, and cell-based therapies targeting a wide range of diseases, including cancer, genetic disorders, autoimmune diseases, and infectious diseases. Pharmaceutical companies invest in research and development (R&D) initiatives to discover and optimize new drug candidates, leveraging genetic engineering platforms and high-throughput screening technologies to identify lead compounds with therapeutic potential. Moreover, pharmaceutical manufacturers utilize genetic engineering to optimize production processes, improve product quality, and ensure compliance with regulatory standards, driving efficiency and innovation in drug manufacturing operations.
Global Genetic Engineering Market, Segmentation by Geography
In this report, the Global Genetic Engineering Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Genetic Engineering Market Share (%), by Geographical Region, 2024
North America emerges as a leading market for genetic engineering, driven by factors such as technological innovation, strong R&D capabilities, and favorable regulatory frameworks supporting biotechnology research and development. The region boasts a robust biotechnology industry, with a concentration of biopharmaceutical companies, academic research institutions, and government research agencies driving advancements in genetic engineering technologies and applications. Additionally, North America benefits from a supportive investment environment, access to venture capital funding, and strategic partnerships between industry stakeholders and academic centers of excellence, fostering innovation and entrepreneurship in the genetic engineering sector. Furthermore, initiatives such as the Precision Medicine Initiative and the BRAIN Initiative in the United States promote collaborative research efforts to advance personalized medicine, neuroscience, and genomics, driving demand for genetic engineering products and services in North America.
Europe represents another significant market for genetic engineering, characterized by a strong scientific base, collaborative research networks, and stringent regulatory oversight governing biotechnology activities. The region boasts a vibrant biotech ecosystem, with clusters of biotechnology hubs and innovation centers driving research and development in genetic engineering, genomics, and personalized medicine. European countries such as the United Kingdom, Germany, and Switzerland are home to leading biopharmaceutical companies, academic research institutes, and biotechnology startups pioneering advancements in gene editing, gene therapy, and synthetic biology. Moreover, European regulatory agencies provide clear guidelines and frameworks for the evaluation and approval of genetically engineered products, ensuring safety, efficacy, and ethical standards in biotechnology research and commercialization. Furthermore, initiatives such as Horizon Europe and the European Research Area promote collaborative research funding and technology transfer, facilitating knowledge exchange and innovation in genetic engineering across Europe.
Asia Pacific emerges as a rapidly growing market for genetic engineering, fueled by factors such as population growth, rising healthcare expenditures, and increasing demand for biotechnology products and services. The region is witnessing significant investments in biotechnology infrastructure, research capabilities, and talent development to capitalize on opportunities in precision medicine, agricultural biotechnology, and industrial applications of genetic engineering. Countries such as China, India, and Singapore are investing in biotechnology R&D, innovation clusters, and regulatory reforms to stimulate entrepreneurship, attract foreign investment, and drive technology transfer in genetic engineering. Additionally, Asia Pacific countries are leveraging genetic engineering to address pressing healthcare challenges, such as infectious diseases, cancer, and genetic disorders, by investing in genomics research, clinical trials, and personalized medicine initiatives. Furthermore, collaborations between Asia Pacific countries and international partners facilitate knowledge sharing, capacity building, and technology transfer in genetic engineering, promoting regional integration and global competitiveness in biotechnology innovation.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Genetic Engineering Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Demand for Genetically Modified Organisms (GMOs)
- Growing Application in Biopharmaceuticals and Therapeutics
- Expanding Biotechnology and Life Sciences Industry
-
Rising Focus on Precision Medicine - The rising focus on precision medicine presents a significant driver for the global genetic engineering market. Precision medicine aims to tailor medical treatment and interventions to individual patients based on their genetic makeup, environmental factors, and lifestyle choices. Genetic engineering plays a crucial role in precision medicine by enabling the identification and manipulation of specific genes associated with disease susceptibility, treatment response, and drug metabolism. As healthcare systems worldwide increasingly prioritize precision medicine initiatives to improve patient outcomes and reduce healthcare costs, the demand for genetic engineering technologies and expertise is expected to grow significantly.
The integration of genetic engineering into clinical practice facilitates the advancement of precision diagnostics and prognostics, enabling earlier disease detection, accurate risk assessment, and personalized treatment planning. Genetic biomarkers and molecular diagnostics play a crucial role in precision medicine by providing insights into disease etiology, progression, and response to therapy. By harnessing genetic information through advanced sequencing technologies, bioinformatics analysis, and molecular profiling techniques, healthcare providers can stratify patients into subpopulations with distinct clinical characteristics and treatment outcomes, guiding personalized treatment decisions and optimizing patient care.
The rising focus on precision medicine underscores the importance of genetic engineering as a foundational tool for advancing personalized healthcare. By harnessing the power of genetic information, researchers and clinicians can develop innovative therapies, diagnostics, and preventive interventions that are tailored to individual patients' unique genetic profiles and healthcare needs. Investing in genetic engineering technologies, research, and infrastructure is essential for driving progress in precision medicine and realizing its potential to revolutionize healthcare delivery and improve patient outcomes on a global scale.
Restraints
- Potential for Off-target Effects in Gene Editing
- Limited Understanding of Genetic Mechanisms
- High Cost of Genetic Engineering Technologies
-
Public Perception and Acceptance - Public perception and acceptance play a crucial role in shaping the trajectory of the global genetic engineering market. As genetic engineering technologies continue to advance and expand into various fields, including agriculture, healthcare, and biotechnology, public attitudes and beliefs regarding the ethical, social, and environmental implications of genetic manipulation influence regulatory policies, research funding, and consumer behavior. Positive public perception and acceptance can facilitate the adoption and commercialization of genetic engineering products and services, while negative perceptions or misconceptions may hinder progress and innovation in the field.
Public perception and acceptance of genetic engineering vary across different regions, cultures, and demographic groups, reflecting diverse perspectives, values, and societal norms. While some individuals may embrace genetic engineering as a tool for addressing global challenges such as food security, disease prevention, and environmental sustainability, others may express reservations or opposition based on ethical, religious, or cultural beliefs. Understanding and respecting the diversity of public opinions and perspectives is essential for fostering constructive dialogue, building public trust, and promoting informed decision-making regarding the use and regulation of genetic engineering technologies.
Public perception and acceptance are critical determinants of the success and sustainability of the global genetic engineering market. By engaging with the public, addressing concerns, and promoting transparency and accountability, stakeholders in the genetic engineering field can cultivate trust, foster acceptance, and facilitate responsible innovation and deployment of genetic engineering technologies. Building public confidence in the safety, efficacy, and ethical implications of genetic engineering is essential for realizing the potential benefits of this transformative technology and addressing societal challenges in a responsible and sustainable manner.
Opportunities
- Expansion into Agricultural Biotechnology
- Integration of Gene Editing in Drug Discovery
- Collaboration with Academic and Research Institutions
-
Focus on Synthetic Biology and Gene Synthesis - The focus on synthetic biology and gene synthesis represents a significant opportunity for innovation and growth in the global genetic engineering market. Synthetic biology combines principles from biology, engineering, and computer science to design and construct artificial biological systems or modify existing organisms for specific purposes. Gene synthesis, a key component of synthetic biology, involves the chemical synthesis of DNA sequences encoding genes or genetic elements, enabling the creation of custom-designed genetic constructs with precise control over sequence, structure, and function. The ability to engineer and synthesize genes has transformative implications for various applications, including biopharmaceuticals, industrial biotechnology, agriculture, and environmental remediation.
The democratization of gene synthesis technologies and the emergence of commercial gene synthesis providers have democratized access to custom DNA synthesis services, enabling researchers, entrepreneurs, and innovators to design and engineer biological systems for a wide range of applications. Cloud-based platforms and online marketplaces for gene synthesis offer convenient and cost-effective solutions for ordering custom DNA constructs, gene fragments, or entire genomes with rapid turnaround times and high-quality synthesis. This accessibility and democratization of gene synthesis empower researchers and industries worldwide to explore new frontiers in synthetic biology, accelerate scientific discovery, and translate genetic engineering innovations into real-world solutions for healthcare, agriculture, and industrial biotechnology.
The focus on synthetic biology and gene synthesis represents a transformative paradigm shift in genetic engineering, enabling precise control over biological systems and unlocking new possibilities for innovation and discovery. By leveraging gene synthesis technologies, researchers and industries can engineer custom-designed genetic constructs, metabolic pathways, and microbial systems for diverse applications, from biopharmaceutical production to environmental remediation. The democratization of gene synthesis accelerates the pace of scientific discovery and technology development, democratizes access to genetic engineering tools and services, and catalyzes the emergence of a vibrant and dynamic ecosystem of synthetic biology innovation and entrepreneurship.
Competitive Landscape Analysis
Key players in Global Genetic Engineering Market include :
- Thermo Fisher Scientific Inc
- GenScript
- Amgen Inc
- Genentech
- Merck KGaA
- Horizon Discovery Group plc
- Sangamo Therapeutics
- Transposagen Biopharmaceuticals
- OriGene Technologies
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
-
Market Snapshot, By Devices
- Market Snapshot, By Techniques
- Market Snapshot, By End User
- Market Snapshot, By Region
-
- Global Genetic Engineering Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Demand for Genetically Modified Organisms (GMOs)
- Growing Application in Biopharmaceuticals and Therapeutics
- Expanding Biotechnology and Life Sciences Industry
- Rising Focus on Precision Medicine
- Restraints
- Potential for Off-target Effects in Gene Editing
- Limited Understanding of Genetic Mechanisms
- High Cost of Genetic Engineering Technologies
- Public Perception and Acceptance
- Opportunities
- Expansion into Agricultural Biotechnology
- Integration of Gene Editing in Drug Discovery
- Collaboration with Academic and Research Institutions
- Focus on Synthetic Biology and Gene Synthesis
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Genetic Engineering Market, By Devices, 2021 - 2031 (USD Million)
- PCR
- Gene Gun
- Gel Assemblies
- Global Genetic Engineering Market, By Techniques, 2021 - 2031 (USD Million)
- Artificial Selection
- Cloning
- Gene Splicing
- Others
- Global Genetic Engineering Market, By End User, 2021 - 2031 (USD Million)
- Research Institutes
- Academic Institutes
- Pharmaceutical Industries
- Others
- Global Genetic Engineering Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Genetic Engineering Market, By Devices, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc
- GenScript
- Amgen Inc
- Genentech
- Merck KGaA
- Horizon Discovery Group plc
- Sangamo Therapeutics
- Transposagen Biopharmaceuticals
- OriGene Technologies
- Company Profiles
- Analyst Views
- Future Outlook of the Market